EP4281046
NALTREXONE COMPOSITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.1.2022EP published:
10.9.2025EP application number:
22702657.2
EPO information:
European Patent Register
Max expiry date:
24.1.2042
Title in English:
NALTREXONE COMPOSITIONSLanguage of the patent:
English
Timeline
Today
25.1.2022EP application
10.9.2025EP Publication
Owner
Name:
LDN Pharma LimitedAddress:
45 Gresham Street, London EC2V 7BG, GB
Inventor
Name:
HOOD, FrancisAddress:
London EC2R 6AY, GB
Priority
Number:
21153332Date:
25.1.2021Country:
EP
Classification
Categories:
A61K 9/20, A61K 9/24, A61K 9/19, A61K 31/485, A61K 31/593, A61P 35/00